Prolaris test aids in decision making on multimodal therapy in prostate cancer


“I find [the Prolaris test] to be a very helpful clinical tool,” says Jonathan D. Tward, MD, PhD.

In this video, Jonathan D. Tward, MD, PhD, discusses findings from the study, “Association of the clinical cell-cycle risk score with metastasis after radiation therapy and identification of men with prostate cancer who can forgo combined androgen deprivation therapy,” which was presented at the 2021 Genitourinary Cancers Symposium. Tward is a professor of radiation oncology at the University of Utah, Salt Lake City.

Related Videos
blur image background of corridor in hospital or clinic image | Image Credit @ whyframeshot -
Male and female surgeon performing surgery | Image Credit: © Georgii -
 Licensed   FILE #:  458906503  Preview Crop  Find Similar  Expand Image DIMENSIONS 8000 x 5333px FILE TYPE JPEG CATEGORY The Environment LICENSE TYPE Standard or Extended A lake in the shape of a recycling sign in the middle of untouched nature | Image Credit: © malp -
Dr. Mehmet Asim Bilen in an interview with Urology Times
blurred clinic hallway
Female doctor using laptop | Image Credit: © nenetus -
Related Content
© 2024 MJH Life Sciences

All rights reserved.